glp-1 for weight loss Top Agonists Balance Efficacy, Safety Study finds GLP-1 receptor agonists

In treating diabetes, when constipation is an issue, I already switch between Ozempic, the older GLP-1 medicines Victoza and Trulicity, and the newer Mounjaro

Nu-U.Ai | Post GLP-1 forum & AI chatbot SaaS company profile on GetLatka revenue, ARR, valuation, funding rounds, customers, team size, and growth.

with a GLP-1

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

The majority of T2D management is in primary care, where clinicians (medical, nursing and pharmacist staff) play an important role in addressing patient needs and achieving treatment goals

This study included 41 participants (RYGB: n=21, OAGB: n=20) from the randomized RYSA trial with similar amounts of bypassed intestine between the procedures